News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
PDL BioPharma, Inc. Elects Paul Sandman and John McLaughlin to Its Board of Directors
October 13, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
REDWOOD CITY, CA--(Marketwire - October 10, 2008) - PDL BioPharma, Inc. (NASDAQ: PDLI) today announced the election of Paul W. Sandman and John P. McLaughlin to the company's board of directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Venture capital
AI-fueled Isomorphic bags $2.1B, the second largest biotech round ever
May 13, 2026
·
2 min read
·
Tristan Manalac
FDA
FDA’s Makary to resign after Secretary Kennedy signs off
May 12, 2026
·
4 min read
·
Annalee Armstrong
Business
BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal
May 12, 2026
·
2 min read
·
Tristan Manalac
Earnings
Daiichi takes $850M charge, axes facility investment as ADC demand forecast falls
May 11, 2026
·
2 min read
·
Nick Paul Taylor
